BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16988586)

  • 1. Recent advances in immunotherapy for human glioma.
    Carpentier AF; Meng Y
    Curr Opin Oncol; 2006 Nov; 18(6):631-6. PubMed ID: 16988586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel immunotherapeutic approaches to glioma.
    Yamanaka R
    Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell-based glioma immunotherapy (review).
    Yamanaka R; Yajima N; Abe T; Tsuchiya N; Homma J; Narita M; Takahashi M; Tanaka R
    Int J Oncol; 2003 Jul; 23(1):5-15. PubMed ID: 12792771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in human glioblastoma.
    Szabo AT; Carpentier AF
    Rev Neurol (Paris); 2011 Oct; 167(10):668-72. PubMed ID: 21885075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
    Liu G; Black KL; Yu JS
    Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peptide vaccination therapy for malignant glioma].
    Yamanaka R; Itoh K
    Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor immunity and immunotherapy.
    Boura P; Kountouras J; Lygidakis NJ
    Hepatogastroenterology; 2001; 48(40):1040-4. PubMed ID: 11490795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
    Yu JS; Luptrawan A; Black KL; Liu G
    Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells as therapeutic vaccines against cancer.
    Banchereau J; Palucka AK
    Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
    Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
    Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for human glioma: innovative approaches and recent results.
    Hussain SF; Heimberger AB
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):777-90. PubMed ID: 16221048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dendritic cell therapy for malignant glioma].
    Yamanaka R; Homma J; Yajima N; Tsuchiya N; Tanaka R
    No To Shinkei; 2003 Sep; 55(9):771-80. PubMed ID: 14571839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunotherapy of prostate and bladder cancer.
    Totterman TH; Loskog A; Essand M
    BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.
    Schott M
    Endocr Relat Cancer; 2006 Sep; 13(3):779-95. PubMed ID: 16954430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
    Conroy H; Marshall NA; Mills KH
    Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells in cancer immunotherapy - a short review.
    Wojas K; Tabarkiewicz J; Roliński J
    Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.